K-Effervescent Tablets and Ranibizumab Intraocular
Determining the interaction of K-Effervescent Tablets and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: potassium bicarbonate
Brand name: Effervescent Potassium, K-Effervescent, K-vescent, K-vescent, K+Care ET, Klor-Con/EF, Effer-K, Quick-K
Synonyms: K-Effervescent
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- K-Effervescent Tablets-Ranibizumab ophthalmic
- K-Effervescent Tablets-Ranitidine
- K-Effervescent Tablets-Ranitidine Capsule
- K-Effervescent Tablets-Ranitidine Hydrochloride
- K-Effervescent Tablets-Ranitidine Injection
- K-Effervescent Tablets-Ranitidine Suspension
- Ranibizumab Intraocular-K-Lyte/Cl
- Ranibizumab Intraocular-K-Phos M.F.
- Ranibizumab Intraocular-K-Phos Neutral
- Ranibizumab Intraocular-K-Phos No. 2
- Ranibizumab Intraocular-K-Phos Original
- Ranibizumab Intraocular-K-Prime